Rezolute, Inc. — Director's Dealing 2014

May 2, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AntriaBio, Inc. (ANTB)
CIK: 0001509261
Period of Report: 2014-04-30

Reporting Person: Mantripragada Sankaram (Chief Scientific Officer, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-04-30	Stock Option (right to buy)	$3.12	S	500000	Acquired	2019-04-30	Common Stock (500000)	Direct

Footnotes

F1: The option vests in forty-eight equal installments beginning on the date so indicated and every month thereafter, such grant vested in full at 4 years.